REE Automotive to delist from Nasdaq following minimum bid deficiency

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

CoreWeave (CRWV) shares dropped nearly 5% to below $80 after announcing a $3 billion convertible debt offering and a potential $2.92 billion equity raise to fund infrastructure expansion. The company aims to use proceeds for growth and to offset shareholder dilution, but the financing plans highlight its capital-intensive expansion and dependence on external funding.

GE Aerospace's CFO addressed durability concerns about the GE9X engine, assuring no delay for Boeing's 777X. The company redesigned the component and began shipping updated engines. GE's stock is trading at $313.47, 15.6% above its GF Value™ of $271.20, indicating modest overvaluation. The company's GF Score™ is 76/100, with strong momentum but mixed insider and guru activity.

Credit Acceptance Corp. agreed to a $700M settlement, including $630M in debt relief, $60M in restitution, and $15.5M in penalties. The deal, led by New York AG Letitia James and 39 other states, covers 55,000 borrowers. The company must change its default handling and add-on product sales practices. The settlement resolves allegations of predatory lending and misrepresentation of loan terms.

JPMorgan Chase (JPM) plans to invest $750 billion by 2035 to boost U.S. housing supply, including financing 1 million affordable units and aiding 500,000 homebuyers. The bank reported record Q2 net income of $21.2 billion, supporting its expanded housing efforts. Potential benefits include increased mortgage revenue and customer relationships, but risks include credit exposure and market conditions.

Axon Enterprise's stock rebounded 6% to $468 on Wednesday after a 10% drop following a $1 billion convertible notes offering. The company expects 32-34% revenue growth in 2026, with strong Q4 growth anticipated. Analysts maintain bullish targets, citing Axon's faster expansion compared to competitors like Motorola Solutions. The stock has an implied upside of 56% based on a valuation model target of $706.